Northern Trust Corp Immuno Precise Antibodies Ltd. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 41,106 shares of IPA stock, worth $16,853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,106
Previous 50,730
18.97%
Holding current value
$16,853
Previous $32,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$640,1460.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$32,0610.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$16,8920.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$14,4750.0% of portfolio
-
Gradient Capital Advisors, LLC26.8KShares$10,9910.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $10.2M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...